Skip to main content
. 2025 Aug 25;12:e66092. doi: 10.2196/66092

Table 3. Changes in psychosocial outcomes over 6 months (N=34).

Outcome Values, mean (SD) Mean change (SD)
at 3 monthsa
Mean change (SD)
at 6 monthsb
Effect size at 3 monthsc Effect size at 6 monthsd
Baseline 3 months 6 months
Intervention Control Intervention Control Intervention Control Intervention Control Intervention Control
Familiarity 22.0 (12.3) 28.9 (13.1) 26.4 (13.5) 33.2 (16.5) 31.1 (11.7) 31.1 (14.6) 3.1 (7.1) 1.7 (8.2) 9.1 (9.6) 1.6 (7.1) 0.11 0.58
Comprehension 5.7 (3.6) 4.4 (3.7) 7.6 (3.6) 5.6 (4.4) 7.7 (4.0) 7.3 (3.8) 2.2 (3.5) 1.2 (3.7) 2.1 (4.5) 2.9 (4.0) 0.27 −0.22
Reading ability 6.6 (3.2) 6.1 (4.2) 7.7 (2.4) 9.2 (3.1) 9.4 (2.1) 9.0 (3.1) 0.7 (2.9) 0.7 (4.6) 2.8 (2.4) 2.4 (3.8) 0 0.1
MOS-SSe,f 27.5 (6.0) 30.4 (7.1) —g — 29.8 (7.3) 30.2 (6.5) — — 2.3 (8.0) −0.2 (3.7) — 0.37
Self-Efficacy-Bh 10.7 (1.4) 11.1 (1.9) 10.5 (1.7) 11.1 (2.1) 10.7 (1.7) 11.0 (1.8) −0.1 (1.8) 0.0 (1.3) 0.0 (1.8) −0.1 (1.6) −0.06 0.06
Self-Efficacy-Ci 10.5 (1.5) 11.2 (1.6) 10.4 (1.9) 11.3 (2.1) 10.7 (1.4) 11.3 (1.8) 0.1 (2.2) 0.1 (1.8) 0.3 (1.5) 0.2 (2.1) 0 0.06
EQ-5De 8.7 (1.8) 9.7 (0.7) — — 7.9 (2.0) 8.1 (2.2) — — −0.8 (2.0) −1.7 (2.3) — 0.65
a

Mean change from baseline to 3 months.

b

Mean change from baseline to 6 months.

c

Difference in mean change from baseline to 3 months divided by the pooled SD at baseline.

d

Difference in mean change from baseline to 6 months divided by the pooled SD at baseline.

e

Assessment performed at baseline and 6 months only.

f

MOS-SS: Medical Outcomes Survey-Social Support.

g

Not applicable.

h

Self-Efficacy-B: Self-Efficacy-Breast Cancer.

i

Self-Efficacy-C: Self-Efficacy-Cervical Cancer.